ACCURAY INC (ARAY)
CIK 1138723 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 119.0M shares as of Apr 30, 2026 (10-Q).
Cash runway
Self-funding
generates cash
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| Premium Warrants | 17.2M | $1.68 | — | FV $16.5M |
| June2025 Penny Warrants | 6.2M | $0.01 | — | — |
| December2025 Super Premium Warrants | 3.1M | $1.5 | — | — |
| December2025 Premium Warrants | 2.2M | $1.25 | — | — |
| December2025 Penny Warrants | 1.8M | $0.01 | — | — |
| Penny Warrants | not tagged | not tagged | — | FV $3.1M |
| Term Loan Facilities Due2030 | not tagged | not tagged | — | FV $22.7M |
Tranches exactly as the company dimensioned them in its 10-Q filed May 6, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Balance-sheet fair value of warrants: $10.4M as of Sep 30, 2025.
Convertible notes
| Note | Principal | Carrying | Conv. price | Rate | If converted |
|---|---|---|---|---|---|
| Convertible Senior Notes Due June 12026 | $100.0M | $18.0M | $5.86 | 3.75% | ~17.1M sh |
If every note above converted at its tagged price: ~17.1M new shares on 119.0M currently outstanding. An estimate from principal ÷ conversion price, with inputs carrying different as-of dates; make-whole adjustments, capped calls and partial repurchases are not modeled.
Notes exactly as the company dimensioned them in its 10-Q filed May 6, 2026 →. Principal is face amount as tagged, not what remains after repurchases unless the filer updated the tag. A note the filer did not dimension is absent here, not absent from the balance sheet; the exhibits stay the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 119.0M | Apr 30, 2026 |
| + Premium Warrants (if exercised) | 17.2M | Jun 6, 2025 |
| + June2025 Penny Warrants (if exercised) | 6.2M | Jun 6, 2025 |
| + December2025 Super Premium Warrants (if exercised) | 3.1M | Dec 15, 2025 |
| + December2025 Premium Warrants (if exercised) | 2.2M | Dec 15, 2025 |
| + December2025 Penny Warrants (if exercised) | 1.8M | Dec 15, 2025 |
| + Convertible Senior Notes Due June 12026 (if fully converted) | 17.1M | May 31, 2021 |
| Fully diluted estimate | 166.5M | +39.9% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Registered offering capacity on live registrations: $5.3Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted
Last 12 months: 2 executed · 2 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full ARAY workspace